Skip to main content
. 2022 Sep 1;10(9):2158. doi: 10.3390/biomedicines10092158

Figure 2.

Figure 2

Heterogenous ADCs produced using conventional conjugation methods. Linking between the payload molecule and the antibody can happen across any of the available residues. Therefore, the drug-to-antibody ratio and the ADC configuration can differ. It is difficult to control this using conventional conjugation methods, and the properties of the conjugates vary as a result.